Short Communication
477
Spectral data for selected products
1
2
.2.a N-[Phenyl-(2-hydroxy-naphthalen-1-yl)-methyl]-acetamide (Table 1, entry 1). H NMR
(
500 MHz, DMSO-d ): δ = 1.98 (s, 3H), 7.19-1.10 (m, 4H), 7.26-7.20 (m, 4H), 7.33 (t, J = 7.5
6
Hz, 1H), 7.74 (d, J = 9.2 Hz, 1H,), 7.80 (d, J = 8.0 Hz, 1H), 7.84 (s, 1H), 8.45 (d, J = 8.5 Hz,
1
3
1
1
3
H), 10.02 (s, 1H); C NMR (125 MHz, DMSO-d ): δ = 23.2, 40.4, 119.2, 119.4, 122.9, 123.8,
6
-1
26.6, 126.9, 128.5, 128.7, 128.9, 129.1, 129.8, 132.9, 143.1, 153.7, 169.1; IR (KBr, cm ):
399, 3246, 3062, 1640, 1582, 1514, 1372, 1337, 1060.
2
3
2
.2.b N-[(2,5-Dimethoxyphenyl)-(2-hydroxynapthalen-1-yl)-methyl]-acetamide (Table 1, entry
1
). H NMR (500 MHz, DMSO-d ): δ = 1.88 (s, 3H), 3.48 (s, 3H), 3.64 (s, 3H), 6.77-6.72 (m,
6
13
H), 7.23-7.10 (m, 4H), 7.39 (s, 1H), 7.73-7.66 (m, 2H), 8.27-8.15 (m, 2H), 9.75 (s, 1H);
C
NMR (125 MHz, DMSO-d ): δ = 22.5, 44.4, 55.2, 55.9, 111.1, 111.9, 115.7, 118.5, 118.9,
6
-
1
1
3
7
2
22.0, 123.2, 125.7, 128.1, 128.6,131.7, 132.4, 150.7, 152.7, 153.1, 168.1; IR (KBr, cm ):
365, 3174, 3002, 2939, 1614, 1577, 1497, 1436, 1370, 1317, 1277, 1218, 1084, 1052, 819,
97, 727; MS (EI, 70 eV) m/z = 351 (M+, 18%), 308 (6%), 276 (6%), 262 (36%), 261 (100%),
18 (17%), 205 (3%), 189 (5%), 164 (4%), 144 (7%), 115 (8%), 95 (2%), 77 (2%).
ACKNOWLEDGEMENTS
We gratefully acknowledge the financial support from the Research Council of Islamic Azad
University, Firoozabad Branch. We are also grateful to Mohammad Barekat for preparing some
of the starting materials.
REFERENCES
1
2
3
. Zhu, J.; Bienayme, H. Multicomponent Reactions, 1st ed., Wiley-VCH: Weinheim; 2005; p
3.
. Thomas, J.M.; Thomas, W.J. Principles and Practice of Heterogeneous Catalysis, 3rd
ed, Wiley-VCH: Weinheim; 1997, p 1.
. Dingermann, T.; Steinhilber, D.; Folkers, G. Molecular Biology in Medicinal Chemistry, 1st
ed., Wiley-VCH: New York; 2004; p 323.
3
4
5
6
7
. Shen, A.Y.; Tsai, C.T.; Chen, C.L. Eur. J. Med. Chem. 1999, 34, 877.
. Kantevari, S.; Vuppalapati, S.V.N.; Nagarapu, L. Catal. Commun. 2007, 8, 1857.
. Selvam, N.P.; Perumal, P.T. Tetrahedron Lett. 2006, 47, 7481.
. Das, B.; Laxminarayana, K.; Ravikanth, B.; Rao, B.R. J. Mol. Catal. A: Chem. 2007, 261,
1
80.
8
9
1
1
1
1
1
1
1
. Nagarapu, L.; Baseeruddin, M.; Apuri, S.; Kantevari, S. Catal. Commun. 2007, 8, 1729.
. Shaterian, H.R.; Yarahmadi, H.; Ghashang, M. Bioorg. Med. Chem. Lett. 2008, 18, 788.
0. Wang, M.; Liang, Y. Monatsh. Chem. 2011, 142, 153.
1. Soleimani, E.; Zainali, M. Synth. Commun. 2012, 42, 1885.
2. Shaterian, H.R.; Ghashang, M.; Asadi, M.; Riki, N.T. J. Iran. Chem. Soc. 2012, 9, 1.
3. Zali, A.; Shokrolahi, A. Chin. Chem. Lett. 2012, 23, 269.
4. Kotadia, D.A.; Soni, S.S. J. Mol. Catal. A: Chem. 2012, 353, 44.
5. Yarahmadi, H.; Shaterian, H. R. J. Chem. Res. 2012, 36, 52.
6. Zolfigol, M.A.; Khazaei, A.; Moosavi-Zare, A.R.; Zare, A.; Khakyzadeh, V. Appl. Catal. A:
Gen. 2011, 400, 70.
1
1
1
7. Karimi-Jaberi, Z. Keshavarzi, M. Chin. Chem. Lett. 2010, 21, 547.
8. Karimi-Jaberi, Z.; Amiri, M. Heteroatom Chem. 2010, 21, 96.
9. Karimi-Jaberi, Z.; Zarei, L. S. Afr. J. Chem., 2012, 65, 36.
Bull. Chem. Soc. Ethiop. 2012, 26(3)